ALZN
Alzamend Neuro Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.04
-0.05 ▼ -2.39%
🌙 3월 13일 4:52 PM ET (한국 3/14 05:52)
$2.08
+0.04 ▲ +1.87%
| Index | - | P/E | - | EPS (ttm) | -4.38 | Insider Own | 2.53% | Shs Outstand | 0.00B | Perf Week | 3.03% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | -3.17% | Insider Trans | -87.38% | Shs Float | 0.00B | Perf Month | 14.61% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.53 | Inst Own | 6.46% | Short Float | 7.27% | Perf Quarter | -5.56% |
| Income | -0.01B | P/S | - | EPS this Y | 76.38% | Inst Trans | 2% | Short Ratio | 3.64 | Perf Half Y | -15% |
| Sales | 0.00B | P/B | 3.55 | EPS next 5Y | - | ROA | -171.39% | Short Interest | 0.27M | Perf YTD | 12.09% |
| Book/sh | 0.57 | P/C | 2.86 | EPS past 3/5Y | 60.75% 30.49% | ROE | -249.97% | 52W High | -79.94% ($10.17) | Perf Year | -67.14% |
| Cash/sh | 0.71 | P/FCF | - | Sales past 3/5Y | - | ROIC | -349.37% | 52W Low | 29.11% ($1.58) | Perf 3Y | -99.7% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 84.12% | Gross Margin | - | Volatility(W/M) | 8.23% 8.02% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.15 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.99 | EPS Q/Q | 65.91% | Profit Margin | - | RSI (14) | 50.46 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.99 | Sales Q/Q | - | SMA20 | 2.56% ($1.99) | Beta | -0.3 | Target Price | $28 |
| Payout | - | Debt/Eq | 0 | Earnings | 2025/12/31 | SMA50 | -1.75% ($2.08) | Rel Volume | 0.79 | Prev Close | $2.09 |
| Employees | 7 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -16.85% ($2.45) | Avg Volume(3M) | 0.07M | Price | $2.04 |
| IPO | 2021/6/15 | Option/Short | No/Yes | Trades | 283 | Volume | 58,434 | Change | -2.39% |
뉴스 로딩 중...